Medica compamed

20
France - Bretagne Pavilions MEDICA & COMPAMED 14>17 November 2016 Exhibitors & visitor list Halls 3 - 8B - 16 - 17 Düsseldorf, Germany

Transcript of Medica compamed

Page 1: Medica compamed

France - Bretagne PavilionsMEDICA & COMPAMED

14>17 November 2016

Exhibitors & visitor listHalls 3 - 8B - 16 - 17

Düsseldorf, Germany

Page 2: Medica compamed

EXHIBITORS

ALLIANCE BIO EXPERTISE

AMAROK

B<>COM

DIAFIR

ID2SANTE

INNOVATIVE MEDICAL PARTNERS

LE GUELLEC TUBES

NG BIOTECH

NOWAK MEDICAL

THERENVA

VISITOR

MEDISONIC

ACCOMPANIED BY

BRETAGNE COMMERCE INTERNATIONAL

Stand

HALL 03 / H64

HALL 16 / D54

HALL 17 / B54

HALL 16 / D54

HALL 16 / D54

HALL 16 / D54

HALL 08B / F12

HALL 03 / H74

HALL 08B / E12

HALL 16 / D54

HALL 16 / D54E

Page

4

5

6

7

8

9

10

11

12

13

14

15

Index of Companies

2

Page 3: Medica compamed

Floor Plan

3

France Bretagne

Pavilions

Page 4: Medica compamed

Contact: Aurélien BLANCHARD

Hall 03 / H64

ZA de Courbouton - Le Tremplin35 480 GUIPRY-MESSACFRANCETel.: +33 (0)2 40 51 79 [email protected]

ALLIANCE BIO EXPERTISE designs, manufactures &provides innovative solutions for worldwidelaboratories. Our team is putting his expertise at theservice of lab customers, by offering turnkey, tailor-made solutions for Pharma, Food, Cosmetics, Clinicaland Research laboratories.

A.B.E manufactures a full range of own designedlaboratory automates (gravimetric diluters, blenders,automated media preparators, automated mediapourer stackers, automated tube fillers, airsamplers) aswell as a new generation of Centrifuges.

A.B.E is launching its brand new innovative MEDIAWEL2-30, Automated Media Preparator. It provides highfertility, sterility and homogeneous quality of all mediaprepared in a short time. Flexible from 2 to 30 Liters agar & broth preparations,leaving almost no dead volumes, whole bowl stirrerdevice, new touch screen with traceability charts,adequate cleaning spaces, etc.

4

Alliance Bio Expertise

Page 5: Medica compamed

Amarok Biotechnologies

Contact: Vincent GENTY

Hall 16 / D54

3 impasse du Grand Jardin35 400 SAINT-MALO

FRANCETel.: +33 (0)2 99 81 08 09

[email protected]

AMAROK BIOTECHNOLOGIES is a private lab, specializedin methods, reagents and analytical systems validationfor regulatory registrations. Our main partners are IVDdiagnostic firms.

We also realize Contract Research Programs inbiotechnologies.

5

Page 6: Medica compamed

Contact: Carole LE GOFF

Hall 17 / B54

1219 avanue des Champs Blancs35510 CESSON-SEVIGNEFRANCETel.: +33 (0)2 56 35 88 [email protected]

@IRT_BCom

B<>COM Institute of Research & Technology developstools, products and services in Hypermedia andultra-high speed Networks. These innovations are usedin the e-Health field to contribute to the digitalrevolution going on in medicine. The e-Health labsdevelop solutions in connected health (DICOM imagessharing and distributed data in order to improveanalysis and diagnosis) and augmented health (surgicalworkflow, image guided surgery, images merging,augmented reality).

B<>COM “Surge Track” solution is a surgical workflowediting and analytics application. It is a user friendlyapplication for surgery conduct and proceduresoptimization as well as for surgical procedure modellingand training.

6

B<>COM

Page 7: Medica compamed

Diafir

Contact: Hugues TARIEL

Hall 16 / D54

Parc LORANS, 26JAvenue Chardonnet

35000 RENNESFRANCE

Tel.: +33 (0)2 99 67 15 [email protected]

www.diafir.com

DIAFIR provides “Point Of Care” diagnostic devices thatdeliver within minutes a metabolic fingerprint out of a7µl drop of fluid. This global information, more comprehensive thandiscrete biomarkers, is used by proprietary algorithmsto provide diagnostic, operator independent. First applications are infectious disease detection(septic arthritis, ascites spontaneous peritonitis, etc.),chronic disease screening (NAFLD/ NASH, etc.) or tumorsdetection (bladder cancer follow up, etc.).

DIAFIR introduced at EASL International Liver Congress,in Barcelona, Spain, NASHMIR, a non invasive “Point OfCare Nash” non invasive diagnostic for morbid obesepatients. The first blood test for this phenotype.

7

Page 8: Medica compamed

8

Contact: Roxanne AMELOT

Hall 16 / D54

2 avenue du Professeur LéonBernard35 043 RENNESFRANCETel.: +33 (0)6 83 85 62 [email protected]

@ID2SANTE

ID2SANTE is a technology innovation centre operatingin Bretagne (Western France). It is in close contact withresearchers and companies from the health sector andhelps forge partnerships to develop innovative healthprojects.It is able to connect you with regional key players andexperts in areas such as:

Medical technologies with diagnostic and therapeuticpurposes (medical devices, computer assisted surgery,imaging, intraocular implants, orthopedic implants)E-health, telemedicine, big data processingNew therapeutic solutions with biotech and

pharmaceuticals.

ID2Santé

• •

Page 9: Medica compamed

9

Innovative Medical Partners

Contact: Gwenael ANNEE

Hall 16 / D54

Le Prisme - Place Albert EinsteinCS 72 001 - Le Prisme

56 038 VANNES CedexFRANCE

Tel.: +33 (0)7 71 76 26 [email protected]

www.medpackrea.com

Mobile medical teams have historically had to work insub-optimal conditions creating potential risks to theirpatients. Born on the field within the Paris fire brigade,MEDPACKREA is a state-of-the-art mobile structure tosupport EMS developed by INNOVATIVE MEDICALPARTNERS, a French Start-up.

MEDPACKREA is manifold : it provides lighting, handcleansing, waste management, a phial-breaker, atelescopic infusion pole, two working tables, etc.

MEDPACKREA brings hygienic standards andeffectiveness in places where resourcefulness rules.

Page 10: Medica compamed

10

Contact: Dominique GUIAVARCH

Hall 08B / F12

ZI de Pouldavid9 rue du Pont Dinou29 177 DOUARNENEZFRANCETel.: +33 (0)2 98 92 08 [email protected]

LE GUELLEC TUBES & PROFILES is specialized in theproduction of precision metal tubing and profiles formedical applications (endoscopes, surgical instruments,laboratory equipment, etc.).

Our core business is the manufacture of small thin tubesin Stainless Steel (316L, 316LVM, 904L, Phynox) and Nickelbased alloys. Precision bars and other alloys are alsoavailable on request.

Diverse cutting, machining, bending & passivationcapabilities are also available in-house.

Le Guellec Tubes

Page 11: Medica compamed

11

NG Biotech

Contact: Milovan STANKOV-PUGES

Hall 03 / H74

ZA de Courbouton - Secteur 135 480 GUIPRY

FRANCETel.: +33 (0)2 23 30 17 83

[email protected]

NG BIOTECH’s patented lateral flow immunoassayplatform offers unique multiplexing, signalamplification and quantitative capabilities. We combineour expertise to a low cost mobile reader and connectedsolution to develop rapid, mobile and connecteddiagnostics. This allows to analyze up to 9 biomarkersfrom a direct sample as finger prick blood in 5 minutesand to get the result on a smartphone for further datacommunication. NG Biotech is ISO13485 certified. Itintegrates R&D and manufacturing in its premises.

NG-Test Zika is a rapid, qualitative and convenientimmunochromatographic in vitro assay for thedeferential detection of IgG & IgM antibodies to Zikavirus in human serum, plasma and/or whole bloodsamples.

Page 12: Medica compamed

12

Contact: Isabelle BARJOU

Hall 08B / E12

ZA - 6 rue du Bélier35 320 PANCEFRANCETel.: +33 (0)2 99 43 01 [email protected]

NOWAK is a French high precision casting company,serving orthopaedic implant manufacturers.

Specialized in cobalt alloys & stainless steel, NOWAKhasan established know-how for producing complex castingthanks to the “lost wax” technology & the rapidprototyping.

Certified ISO 13485 & 9001, NOWAK offers youpersonalized advice, assistance & expertise up toproduction stage.

medical

Nowak Medical

Page 13: Medica compamed

13

Therenva

Contact: Sumiré HIROT

Hall 16 / D54

4 rue Jean Jaurès35 000 RENNES

FRANCETel.: +33 (0)2 99 28 37 [email protected]

www.therenva.com

THERENVA designs and sells medical device softwaresystems and image-based services addressing the needsof surgeons and global implant device manufacturers inthe cardiovascular field. Our leading software suite EndoSize® is a must-haveimage analysis tool for planning the best cardiovasculartreatment and the most appropriate implant for eachpatient. EndoSize is a CE, FDA, and CFDA approvedmedical device.

THERENVA extends its endovascular imaging portfoliowith a new solution based on pre-/intra-operative datafusion. With EndoNaut® in the operating roomproviding precise 3D information, interventionalistshave the ability to deploy devices in a safe way whilereducing X-ray and contrast agent doses.

Page 14: Medica compamed

14

Contacts: Pierre MARCILLEGuillaume BESSON

ZA rue Lucien Rosengart22 190 PLERINFRANCETel.: +33 (0)1 30 34 64 [email protected]

MEDISONIC provides services and products for medicalgas pipeline system:

Engineering, Design on 2d and 3 D CAD,Training, equipment maintenance services an parts,Medical vacuum systems, medical air plants and

medicinal oxygen generators,Gas supply manifold, medical low and high pressure

regulators,Alarm system, hoses, valves, flowmeters, sensors,

gauges,Terminal Units.

Medisonic

• • •

Page 15: Medica compamed

15

Bretagne Commerce International is anon-profit organization of privatecompanies located in Western France. Entrusted by the Regional Governmentof Bretagne and the Regional Chamberof Commerce to internationalize theBreton economy, it assists Bretoncompanies in their internationaldevelopment as well as foreigncompanies planning to invest inBretagne.Through customized and collectiveactivities, Bretagne CommerceInternational is committed to: E Raising awareness aboutinternational businessopportunities

E Supporting companies withadministrative issues

EHelping companies start and thenconsolidate their business.

Bretagne Commerce International

Contact: Annie MUGNIER

Le Colbert35 place du Colombier - CS 71238

35 012 RENNES cedex FRANCE

Tel.: +33 (0)2 99 25 04 [email protected]

www.BretagneCommerceInternational.com@BCInter

Page 16: Medica compamed

16

E From one of the founding countries of the European Union, you will be able toexpand on a market of 502 million consumers with a high purchasing power.

E Thanks to an outstandingly high level of initial education, you will benefit froma workforce which is able to adapt to the constant evolution of products andservices easily.

E Enjoying a high quality of life environment, you will find opportunities forinnovation, R&D and competitiveness, which is the evidence of great scientificand technological skills.

Why invest in Bretagne?

Bretagne plays host to almost 490 foreign companies

• 28,000 km²

• 3.25 million people(+23,000 inhab/year)

• €83,4 billion GDP

• 1st Agri-Food regionin France

• 1st Agriculturalregion in France

• 1st Fishing region

• 1st region forShipbuilding andrepair

• 1st region in MarineScience &Technology

• 1st region for filingof High TechEuropean patentsin France

• 2nd region forDigital R&D inFrance

Land of excellence:

Digital, Automotive, Marine, Agriculture and Agri-Food

Developing sectors:

Marine Renewable Energy, Green Vehicles, Eco-Activities, Biotech, Security & Defence

Bretagne economy: a snapshot

Bretagne and its strong industrial dynamics

Page 17: Medica compamed

17

[email protected]

Focus on HEALTHCARE SECTOR

• 2 universityhospitals (10,000 jobs)

• 198 public orprivatehealthcareestablishments

• 4 universities

• 20 “grandesécoles” (highereducationinstitutions)

• 9 technicalcenters

• 7 high-tech parks

• ID2Santé: theinnovation &technologytransfer center

A rich network

Expertise

e Medical technologies for diagnostics &therapeutics

e E-healthe Biotech & Pharmae Prevention & Health nutrition

Biotech in Bretagne

e #1 French region in Marine biotechnologye #3 French region in Biotechnologye 250 playerse 3 marine biology stations

25 research units dedicated to Health and 35 involved in Health research

+600 researchers

215 companies employing 8,000 persons

Bretagne, innovating for a more integrated managementof Health & Wellbeing

Page 18: Medica compamed

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

Note

Page 19: Medica compamed

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

........................................................................................................................

Note

Page 20: Medica compamed

Bretagne Commerce InternationalLe Colbert • 35 place du Colombier • CS 71238 • 35012 RENNES cedex • FRANCE

Tel.: +33 (0)2 99 25 04 04 • Fax: +33 (0)2 99 25 04 [email protected]

www.BretagneCommerceInternational.com@BCInter